NFKB1 and colitis: The anti-inflammatory properties of several of these compounds are attributed to their influence on intracellular signaling pathways, such as NF-κB and mitogen-activated protein kinases (MAPKs), and their contribution to reducing colitis severity in several rodent models has been documented in vivo [46].